Veru (VERU) Revenue (2012 - 2024)
Veru (VERU) reported Revenue of $6.66 million for fiscal Q4 2024 (quarter ended Sep 30, 2024), up 72.4% from $3.86 million a year earlier and up 68.4% from the prior quarter.
Powered by 
Analysis
Veru (VERU) Revenue (2012 - 2024) Analysis & Trends
For FY2024 (ended Sep 30, 2024), Veru posted Revenue of $16.89 million, up 3.6% from FY2023.
- Revenue has a five-year compound annual growth rate of -11.9% (FY2019 to FY2024).
- By fiscal year, Revenue came in at $16.3 million in FY2023 (-58.6%), $39.35 million in FY2022 (-35.8%), $61.26 million in FY2021 (+43.8%) and $42.59 million in FY2020 (+33.9%).
- The fiscal Q4 2024 figure ranks as the highest quarterly Revenue since fiscal Q3 2022.
- Year over year, Revenue gained in three of the last eight quarters, with an average decline of 13.6%.
- The high point for year-over-year Revenue in five years was fiscal Q4 2024 (growth of 72.4%); the low point was fiscal Q4 2022 (a decline of 83.5%).
- Per Business Quant data, the three fiscal quarters before Q4 2024 came in at $3.95 million (Q3 2024), $4.14 million (Q2 2024) and $2.14 million (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Veru | 59.01 Mn | -51.26 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 6.66 Mn |
| Jun 30, 2024 | 3.95 Mn |
| Mar 31, 2024 | 4.14 Mn |
| Dec 31, 2023 | 2.14 Mn |
| Sep 30, 2023 | 3.86 Mn |
| Jun 30, 2023 | 3.34 Mn |
| Mar 31, 2023 | 6.59 Mn |
| Dec 31, 2022 | 2.51 Mn |
| Sep 30, 2022 | 2.59 Mn |
| Jun 30, 2022 | 9.60 Mn |
| Mar 31, 2022 | 13.03 Mn |
| Dec 31, 2021 | 14.14 Mn |
| Sep 30, 2021 | 15.65 Mn |
| Jun 30, 2021 | 17.66 Mn |
| Mar 31, 2021 | 13.34 Mn |
| Dec 31, 2020 | 14.62 Mn |
| Sep 30, 2020 | 11.75 Mn |
| Jun 30, 2020 | 10.32 Mn |
| Mar 31, 2020 | 9.94 Mn |
| Dec 31, 2019 | 10.58 Mn |
API Access
Veru Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=VERU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "VERU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=VERU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();